期刊文献+

卡维地洛与西拉普利联合应用治疗高血压合并冠心病90例疗效分析 被引量:4

Therapeutic effect of combined medication of Carvedilol and Cilazapril on patients with hypertension complicated with coronary heart disease:report of 90 cases
下载PDF
导出
摘要 目的:探讨卡维地洛与西拉普利联合应用对高血压合并冠心病患者心率、血压、左室重构的影响及抗心绞痛作用.方法:以90例高血压合并冠心病患者为研究对象,采用彩色多谱勒超声技术,测定治疗前、后左室结构和功能,并临床观察、记录治疗前、后血压、心率的变化,心绞痛发作的次数及硝酸甘油的用量.结果:卡维地洛与西拉普利联合应用降血压、减慢心率、抗心绞痛、改善左室舒张功能、逆转左室肥厚等作用明显(P<0.05).结论:卡维地洛与西拉普利联合应用降压、抗心绞痛作用明显,且可全面阻断心室重构、改善心功能. AIM: To study the anti-anginal efficacy of the com- bined medication of Carvedilol and Cilazapril on patients with hy- pertension and coronary heart disease, as well as its effects on heart rate, blood pressure, and left ventricular remodeling. METHODS: Ninety patients with hypertension complicated with coronary disease were included in this study. Color Doppler flow imaging was performed to evaluate the structure and function of left ventricle before and after the combined medication, Changes in blood pressure, heart rate and frequency of attacks as well as the dosage needed to control acute attack of angina were also do- cumented. RESULTS: Carvedilol and Cilazapril, when adminis- tered together, exerted a potent effect on slowing heart rate, relie- ving acute pain of angina pectoris, improving left ventricular dias- tolic function and reversing left ventricular hypertrophy (P 〈 0.05 ). CONCLUSION : The combined medication of Carvedilol and Cilazapril is effective not only in lowering blood pressure and treating angina pectoris, but also in improving ventricular function and preventing left ventricular remodeling.
出处 《第四军医大学学报》 北大核心 2007年第21期2011-2013,共3页 Journal of the Fourth Military Medical University
关键词 卡维地洛 西拉普利 左室重构 冠状动脉疾病 Carvedilol, Cilazapril, left ventricular remodeling,coronary disease
  • 引文网络
  • 相关文献

参考文献13

  • 1Everett AD,Tufro-Mcreddie A,Fisher A,et al.Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-blexpression[J].Hypertension,1994,23:587-592.
  • 2周斌,魏尔清.β受体阻滞药卡维地洛[J].中国新药杂志,1996,5(1):23-26. 被引量:10
  • 3张子树,郑宗锷.充血性心力衰竭[M].北京:科学技术文献出版社,1991.259-260.
  • 4Van Amsterdam FTM,Roveri A,Maioriono ME,et al.Lacidipine:A dihydropyridine calcium antagonist with antioxidant activit[J].Free Radic Biol Med,1993,12:183-187.
  • 5王明屹,胡镇祥.脉冲波多普勒超声心动图评价冠心病左室舒张功能[J].中华心血管病杂志,1992,20(6):341-343. 被引量:10
  • 6Yue TL,Cheng HY,Lysko PG,et al.Carredilol,a new vasodilator and beta adrenoceptor antagonist,is an antioxidant and free radical scavenger[J].J Pharmacol Exp Ther,1992,263:92-98.
  • 7Th MERIT-HF Study group.Effect of metoprolol CR/XL in chronic heart failure:MetoprololCR/XL Randomised Intervention Trial in Congestive Heart failure(MERIT-HF)[J].Lancet,1999,353:2001-2007.
  • 8CIBIS-Ⅱ Investigators.The cardiac insufficiency bisoprolol studyⅡ(CIBIS-Ⅱ):A randomized trial[J].Lancet,1999,353:9-13.
  • 9Packer M,Bristow MR,Cohn JN,et al.The effect of carvedilol on morbidity and morbidity in patients with chronic heart failure[J].N Engl J Med,1996,334:1349-1355.
  • 10Cleland J.Focus on carvedilol for heart failure[J].Heart Fail Rev,1999,4:5-6.

二级参考文献5

  • 1卢兴,心力衰竭,1986年
  • 2Prof. Dr. M. R. Bristow,P. Larrabee,B. Müller-Beckmann,W. Minobe,R. Roden,L. Skerl,J. Klein,D. Handwerger,J. D. Port. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes[J] 1992,The Clinical Investigator(2):S105~S113
  • 3R. R. Ruffolo,C. F. Sauermelch,R. N. Willette. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation[J] 1990,European Journal of Clinical Pharmacology(2):S112~S114
  • 4Dr. J. P. Ollivier,P. Durier,J. L. Bussiere,J. L. Gayet. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension[J] 1990,European Journal of Clinical Pharmacology(2):S164~S166
  • 5E. M?llendorff,K. Reiff,G. Neugebauer. Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker[J] 1987,European Journal of Clinical Pharmacology(5):511~513

共引文献19

同被引文献11

引证文献4

二级引证文献30

;
使用帮助 返回顶部